Expert Ratings For Pacira BioSciences
Expert Ratings For Pacira BioSciences
Pacira Biosciences的专家评级
Pacira BioSciences (NASDAQ:PCRX) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有8位分析师对Pacira BioSciences（纳斯达克股票代码：PCRX）进行了分析，揭示了从看涨到看跌的不同观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $41.88, with a high estimate of $57.00 and a low estimate of $25.00. Highlighting a 8.72% decrease, the current average has fallen from the previous average price target of $45.88.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为41.88美元，最高估计为57.00美元，低估值为25.00美元。当前的平均价格已从之前的45.88美元的平均目标股价有所下降，这凸显了8.72％的跌幅。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
An in-depth analysis of recent analyst...
对分析师近期行...
登录免费看全文
登录/注册